FolioLanternBeta
BIIBBiogen

Nicole Murphy

Head of Pharm Ops and Tech at Biogen, as of Feb 17, 2026In the past 12 months: bought $585 of stock in 1 open-market purchase.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
20K
shares held after the latest filing, Biogen
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
$585
open-market purchases, past 12 months (1 trade)
1
company filed for

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Biogen (BIIB)Head of Pharm Ops and TechFeb 14, 2022Feb 17, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.